Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction.

Alteration of platelet function contributes to microthrombus formation and may play an important role in the pathogenesis of diabetic micro- and macroangiopathies. However, the molecular mechanism for platelet dysfunction observed in patients with diabetes has not been fully elucidated. In this study, the direct effects of hyperglycemia on platelet function in vitro were investigated. Hyperglycemia increased reactive oxygen species generation in human platelets, and this effect was additive with that of collagen. Thenoyltrifluoroacetone (TTFA), an inhibitor of mitochondrial electron transport chain complex II, and carbonyl cyanide m-chlorophenylhydrazone (CCCP), an uncoupler of oxidative phosphorylation, completely prevented the effects of hyperglycemia, suggesting that reactive oxygen species arise from the mitochondrial electron transport chain. Hyperglycemia potentiated both platelet aggregation and the subsequent release of platelet-derived growth factor AB induced by a nonaggregating subthreshold concentration of collagen, which were also completely inhibited by TTFA or CCCP. Furthermore, hyperglycemia was found to inhibit protein tyrosine phosphatase (PTP) activity and increase phosphorylation of the tyrosine kinase Syk in platelets exposed to collagen. Hyperglycemia-induced PTP inhibition and Syk phosphorylation were found to be completely prevented by TTFA, CCCP, or Mn(III)tetrakis (4-benzoic acid) porphyrin, a stable cell-permeable superoxide dismutase mimetic. These results suggest that hyperglycemia-induced mitochondrial superoxide generation may play an important role in platelet dysfunction observed in patients with diabetes.

[1]  Y. Kaneda,et al.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.

[2]  Deepak L. Bhatt,et al.  Abciximab reduces mortality in diabetics following percutaneous coronary intervention. , 2000, Journal of the American College of Cardiology.

[3]  D. Praticò,et al.  Superoxide Anion and Hydroxyl Radical Release by Collagen-induced Platelet Aggregation - Role of Arachidonic Acid Metabolism , 2000, Thrombosis and Haemostasis.

[4]  J. Spivak,et al.  Commentary on and reprint of Born GVR, Aggregation of blood platelets by adenosine diphosphate and its reversal, in Nature (1962) 194:927–929 , 2000 .

[5]  Dale,et al.  Platelet–collagen interactions: membrane receptors and intracellular signalling pathways , 1999, European journal of clinical investigation.

[6]  Luminita Pricop,et al.  Reactive Oxygen Intermediates Enhance Fcγ Receptor Signaling and Amplify Phagocytic Capacity , 1999, The Journal of Immunology.

[7]  K. Sada,et al.  Involvement of reactive oxygen intermediates in lectin-induced protein-tyrosine phosphorylation of Syk in THP-1 cells. , 1998, Biochemical and biophysical research communications.

[8]  P. Gazzaniga,et al.  Hydrogen peroxide is involved in collagen-induced platelet activation. , 1998, Blood.

[9]  V. Todorović,et al.  [Platelet function]. , 1998, Srpski arhiv za celokupno lekarstvo.

[10]  S. Ellis,et al.  Problem of angioplasty in diabetics. , 1997, Circulation.

[11]  M. Turner,et al.  The Fc receptor γ‐chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen , 1997, The EMBO journal.

[12]  J. Chesebro,et al.  Mechanisms Determining Course and Outcome of Diabetic Patients Who Have Had Acute Myocardial Infarction , 1997, Annals of Internal Medicine.

[13]  Y. Minami,et al.  Syk-dependent and -independent Signaling Cascades in B Cells Elicited by Osmotic and Oxidative Stress* , 1997, The Journal of Biological Chemistry.

[14]  P. Keely,et al.  The α2β1 Integrin Is a Necessary Co-receptor for Collagen-induced Activation of Syk and the Subsequent Phosphorylation of Phospholipase Cγ2 in Platelets* , 1996, The Journal of Biological Chemistry.

[15]  Z. Bloomgarden,et al.  Potential mechanisms promoting restenosis in diabetic patients. , 1996, Journal of the American College of Cardiology.

[16]  P. Keely,et al.  The alpha2beta1 integrin is a necessary co-receptor for collagen-induced activation of Syk and the subsequent phosphorylation of phospholipase Cgamma2 in platelets. , 1996, The Journal of biological chemistry.

[17]  S. Haskill,et al.  Integrin-mediated Tyrosine Phosphorylation and Cytokine Message Induction in Monocytic Cells , 1995, The Journal of Biological Chemistry.

[18]  Y. Zick,et al.  Selective inhibition of protein tyrosine phosphatase activities by H2O2 and vanadate in vitro. , 1992, Biochemical and biophysical research communications.

[19]  P. Winocour.  Platelet Abnormalities in Diabetes Mellitus , 1992, Diabetes.

[20]  H. Rifkin,et al.  Ellenberg and Rifkinʼs Diabetes Mellitus: Theory and Practice , 1992 .

[21]  T. Smith,et al.  J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. , 1991, Biochemistry.

[22]  P. Bennett,et al.  Diabetic renal disease in Pima Indians. , 1989, Transplantation proceedings.

[23]  D. Betteridge,et al.  Platelet function, platelet prostanoids and vascular prostacyclin in diabetes mellitus. , 1989, Prostaglandins, leukotrienes, and essential fatty acids.

[24]  H. Hidaka,et al.  The modulatory role of myosin light chain phosphorylation in human platelet activation. , 1986, Biochemical and biophysical research communications.

[25]  R. Ross,et al.  The biology of platelet-derived growth factor , 1986, Cell.

[26]  D. Betteridge,et al.  Platelet Function in Diabetes Mellitus - Studies of Platelet Aggregation in Whole Blood , 1983 .

[27]  A. Cerami,et al.  The biochemistry of the complications of diabetes mellitus. , 1981, Annual review of biochemistry.

[28]  Daniel L. McGee,et al.  Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.

[29]  W. Kannel,et al.  Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.

[30]  P. Halushka,et al.  Platelet function and diabetes mellitus. , 1978, The Medical clinics of North America.

[31]  M. Bern.  Platelet Functions in Diabetes Mellitus , 1978, Diabetes.

[32]  P. Lefèbvre,et al.  [Eye and the diabetes mellitus]. , 1971, Archives d'ophtalmologie et revue generale d'ophtalmologie.

[33]  G. Born,et al.  Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal , 1962, Nature.

[34]  C. Bjerkelund.  Diabetic Renal Disease. , 2009 .